Furthermore, cisplatin can make cancer cells more susceptible to granzyme B by increasing the penetration of cancer cells and the expression of the granzyme-target caspase-3, which mediates the implementation phase of apoptosis [122, 123]. Here, GZMB is linked to cancer.